Navigation Links
Attacking cancer's sweet tooth is effective strategy against tumors

t we could attack but maybe, if we understand exactly all the steps involved, we could devise alternative strategies to attack the same pathway," Fantin said. What makes the prospect of anti-glycolytic therapies even more attractive is their potential safety. Healthy cells meet 90 percent of their energy needs through OXPHOS. People who lack the LDHA enzyme appear to function normally though they cannot be pushed toward anaerobic exercise. "They have muscle destruction because they lack an alternative route for producing energy," Fantin said. It is not clear whether they have a lower indidence of cancer.

Also appealing is the idea of combining anti-glycolytic therapies with anti-angiogenic ones.

"If you have a molecule that is very stable you could think about delivering it first, obliterating the glycolytic pathway," said Fantin. Angiogenesis inhibitors would wipe out blood vessels and the oxygen supply with it, leaving the cells with no way to cope. "There is definite potential to combining these things," she said.


'"/>

Source:Harvard Medical School


Page: 1 2 3

Related biology news :

1. New understanding of cell movement may yield ways to brake cancers spread
2. Catching cancers spread by watching hemoglobin
3. Bad aftertaste? New sensory on/off switch may cure bane of artificial sweetener search
4. Bitter or sweet? The same taste bud can tell the difference
5. UW-Madison scientists zero in on drugs sweet spots
6. Sweet water taste paradoxically predicts sweet taste inhibitors
7. Scientists seek to unwrap the sweet mystery of the sugar coat on bacteria
8. Healing honey: The sweet evidence revealed
9. A sweet solution for Alzheimers disease?
10. Uncovering DNAs sweet secret
11. A sweet step toward new cancer therapies

Post Your Comments:
(Date:12/3/2009)...animal species can be likened to emptying a museum...otential medicines into the trash, or replacing ev... the decline of species and their habitats may not...ests it may also put you at greater risk for catch...nd biodiversity loss,"driven by the replacement of...
(Date:12/3/2009)... , Preliminary Press Conference Topics, Last...ciences museum, Attention PIOs: Sending Press Re...gistration deadline 10 December, News Media regi...orm pre-registration deadline THIS MONDAY, 7 Decem...ion regarding visas for international reporters, p...
(Date:12/3/2009)...ientists believe that staph infections are caused ...emit toxins. The signaling process is called quoru... start the process. , But the Jeff Brinker resea... of staph infection, when bacteria switch from a h...l and that this individual process can be stopped ...
Breaking Biology News(10 mins):Species down, disease up 2Species down, disease up 3Species down, disease up 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3New tool for helping pediatric heart surgery 61999 1New tool for helping pediatric heart surgery 61999 2Metobolomics uncovers key indicators of nonalcoholic fatty liver disease 61997 1Metobolomics uncovers key indicators of nonalcoholic fatty liver disease 61997 2New study finds MRSA on the rise in hospital outpatients 10882 1New study finds MRSA on the rise in hospital outpatients 10882 2
..., the group of marine mammals that includes whales...ry and communicative abilities, as well as complex...vember 27, 2006 in The Anatomical Record, the offi...ists,compared a humpback whale brain with brains f...resence of a certain type of neuron cell that is a...
...rs at the University of Pennsylvania School of Med...t translates blood flow into gene expression. The ...yonic development a transcription factor called Kl..., is activated by rapid, pulsed blood flow, as rep... Understanding Klf2,s role in blood vessel and mus...
...om the University of Liverpool,s School of Biologi...tues which make up Antony Gormley,s ,Another Place...aven for a settlement of a particular breed of bar...s have been present on North West shorelines since...e world on the coasts of Australia. They are neve...
Other Biology News:Humpback whales have brain cells also found in humans 2Humpback whales have brain cells also found in humans 3How blood flow dictates gene expression 2Living laboratory found on shoreline statues 2
(Date:12/2/2009)... LIBREVILLE, Gabon, December 2 ,...yone,s Problem and Heritage" , Coinciding...June 2010 the,Gabonese Republic is hosting an inte...issue of safeguarding biological resources in Afri...and state leaders, ministers,scientific experts, ...
(Date:12/2/2009)..., SINGAPORE, Dec. 2 S*BIO Pte Ltd ...al JAK2 inhibitor, SB1518, at The American Society...in New Orleans. ,, Data will be presented on th...n trial of SB1518 detailing its safety, tolerabili...file in dose levels ranging from 100 to 600 mg. Th...
(Date:12/2/2009)... SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The world... in turmoil and uncertainty is part of many,busine...industry has been,relatively immune to the economi...n. , During the midst of the difficult ti...mp; Johnson inaugurated an R&D center in Shang...
(Date:12/1/2009)...NE VILLAGE, Nev., Dec. 1 ...announced revenue guidance for the fourth quarter ...on, as compared with $69 million for the fourth qu...ults was the first of two installment payments of ...th quarter 2008 results was a one-time $1.8 millio...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3
...nding Google to accept XML feeds from webmasters w...gle recently introduced the beta version of Googl...en listening - at least in part. , ,Google Sitemap...s and other sites with frequently updated or chang...ult listings related to their web site stay fresh ...
...s 100 million people on the Internet, 30 percent o...lion people in Asia will be playing with e-commerc...ing at a phenomenal rate will create global shockw...re continent of Asia, including India and several ...d. The process of this advance is still hard to im...
...the half-year roundup of stock market results for ...f you recall the results from the first quarter, i... Jones down 3 percent , Nasdaq National Market dow...ex Biotech down 9 percent , ,This isnt a great tre...t six months of 2005 werent much better. The only ...
Other Biology Technology:Givin' it to Google: Using an XML Sitemap to Boost Your Site 2Givin' it to Google: Using an XML Sitemap to Boost Your Site 3Huge cyber-tsunami developing in Asia 2Huge cyber-tsunami developing in Asia 3Midwest large cap life sciences mostly outperform market 2Midwest large cap life sciences mostly outperform market 3
...con's 3243 provides all the materials necessary fo...use in CMV antigen studies analysis. Kit Componen...22) One bottle containing 220 mL of buffered ammon...(Catalog No. 5113) One bottle containing 220 mL of...
Rabbit Anti-NO-TRYPTOPHAN CONJUGATE Polyclonal Antibody, Unconjugated from AbD Serotec
Goat Anti-Human SLI Polyclonal Antibody, Unconjugated from AbD Serotec
Mouse Anti-L-DIHYDROXYPHENYLALANINE (L-DOPA) CONJUGATE Monoclonal Antibody, Unconjugated from AbD Serotec
Biology Products: